71904-200Level 3
POMBILITI (cipaglucosidase alfa-atga)
**Product type:** Human Prescription Drug
**Active ingredient:** CIPAGLUCOSIDASE ALFA
**Strength:** 105 mg/1
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** AMICUS THERAPEUTICS US, LLC
**Marketing category:** BLA (BLA761204)
**Pharmacologic class:** Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC], alpha-Glucosidases [CS]
GET
/api/v1/systems/ndc_fda/nodes/71904-200Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.